DOI:
10.1055/s-00000118
Radiologie up2date
LinksClose Window
References
Hahnen E, Lederer B, Hauke J. et al.
Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: Secondary analysis of the GeparSixto randomized clinical trial.
JAMA Oncol 2017;
3: 1378-1385
We do not assume any responsibility for the contents of the web pages of other providers.